Abatacept

SAN DIEGO — A recent FDA approval for systemic sclerosis-associated interstitial lung diseases may portend a new hope for clinicians managing these complicated disorders, according to a presentation at the 2019 Congress of Clinical Rheumatology West.

There are endless idioms about blood. It is thicker than water, but one cannot get it from a stone. Truman Capote wrote about the cold version, rock band Foreigner sang about the hot version. When it comes to rheumatic diseases, researchers are out for blood — blood-based biomarkers, that is.

In this video, Kathryn Dao, MD, associate professor in the department of internal medicine’s division of rheumatology at UT Southwestern Medical Center, discussed recent developments in rheumatoid arthritis treatment, focusing on the major impacts of new guidelines laid out at the recent European Congress of Rheumatology 2022 meeting.